Cargando…

Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?

Detalles Bibliográficos
Autor principal: Kiemer, Alexandra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575427/
https://www.ncbi.nlm.nih.gov/pubmed/33096485
http://dx.doi.org/10.1016/j.ebiom.2020.103086
_version_ 1783597807145320448
author Kiemer, Alexandra K.
author_facet Kiemer, Alexandra K.
author_sort Kiemer, Alexandra K.
collection PubMed
description
format Online
Article
Text
id pubmed-7575427
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75754272020-10-21 Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19? Kiemer, Alexandra K. EBioMedicine Commentary Elsevier 2020-10-21 /pmc/articles/PMC7575427/ /pubmed/33096485 http://dx.doi.org/10.1016/j.ebiom.2020.103086 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Kiemer, Alexandra K.
Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title_full Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title_fullStr Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title_full_unstemmed Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title_short Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19?
title_sort blockade of an innate immune amplifier to fight immune hyperactivation in covid-19?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575427/
https://www.ncbi.nlm.nih.gov/pubmed/33096485
http://dx.doi.org/10.1016/j.ebiom.2020.103086
work_keys_str_mv AT kiemeralexandrak blockadeofaninnateimmuneamplifiertofightimmunehyperactivationincovid19